| 注册
首页|期刊导航|广州医药|复方黄芪颗粒对小鼠抗疲劳的作用及其机制研究

复方黄芪颗粒对小鼠抗疲劳的作用及其机制研究

张志强 张鹏 王松萍 刘江 王晓聪

广州医药2025,Vol.56Issue(4):509-515,7.
广州医药2025,Vol.56Issue(4):509-515,7.DOI:10.20223/j.cnki.1000-8535.2025.04.011

复方黄芪颗粒对小鼠抗疲劳的作用及其机制研究

Study on the anti-fatigue effect of compound Huangqi granules on mice and its mechanism

张志强 1张鹏 1王松萍 2刘江 1王晓聪2

作者信息

  • 1. 深圳市罗湖区人民医院药学部(广东 深圳 518001)
  • 2. 深圳市罗湖区中医院药学部(广东 深圳 518009)
  • 折叠

摘要

Abstract

Objective To investigate the anti-fatigue effects of compound Huangqi granules(CHG)and its mechanism.Methods Forty-eight male BALB/C mice were randomly divided into blank control group,9.1,18.2,27.3 g/kg CHG group(test groups).The test groups received different concentrations of CHG solution by gavage,and the blank control group mice were given equal volume saline.After 30 days of administration,the mice were tested,meanwhile the anti-fatigue effect and mechanism were investigated.Results Compared with blank control group,there was no significant difference in body weight(P>0.05).The exhaustive swimming time and rod turning endurance time of mice were significantly prolonged(P<0.01).The serum levels of blood urea nitrogen,lactate dehydrogenase and malondialdehyde were significantly decreased(P<0.01),while the liver and muscle glycogen levels(P<0.05)and superoxide dismutase activity were increased(P<0.01).In vitro antioxidant tests showed that CHG can remove(1,1-Diphenyl-2-picrylhydrazyl,ABTS)and(2,2'-azino-bis-3-ethylbenzothiazoline-6-sulfonic acid,DPPH)free radicals in a dose-dependent manner.When the CHG concentration is 100 mg/mL,the DPPH free radical scavenging ability of CHG can reach 85.030 3%.When the CHG concentration was 25 mg/mL,the scavenging ability of CHG to ABTS free radicals reached 96.357 2%.Conclusions CHG has anti-fatigue effect,and its mechanism may be related to anti-oxidation effect.

关键词

复方黄芪颗粒/抗疲劳/抗氧化/机制

Key words

compound Huangqi granules/anti-fatigue/anti-oxidation/mechanism

引用本文复制引用

张志强,张鹏,王松萍,刘江,王晓聪..复方黄芪颗粒对小鼠抗疲劳的作用及其机制研究[J].广州医药,2025,56(4):509-515,7.

基金项目

广东省医院协会医院药学科研专项基金项目(YXKY202215) (YXKY202215)

广东省医院药学研究基金项目(2021A16) (2021A16)

深圳市医疗卫生三名工程项目(NO:SZSM202301035) (NO:SZSM202301035)

广州医药

1000-8535

访问量0
|
下载量0
段落导航相关论文